BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8842409)

  • 21. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
    Ganser C; Papazoglou A; Just L; Nikkhah G
    Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade.
    Zeevalk GD; Derr-Yellin E; Nicklas WJ
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1124-30. PubMed ID: 8531072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Astrocyte-dependent and -independent phases of the development and survival of rat embryonic day 14 mesencephalic, dopaminergic neurons in culture.
    Takeshima T; Shimoda K; Sauve Y; Commissiong JW
    Neuroscience; 1994 Jun; 60(3):809-23. PubMed ID: 7936201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.
    McGuire SO; Ling ZD; Lipton JW; Sortwell CE; Collier TJ; Carvey PM
    Exp Neurol; 2001 Jun; 169(2):219-30. PubMed ID: 11358437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for target-specific nerve fiber outgrowth from subpopulations of grafted dopaminergic neurons: a retrograde tracing study using in oculo and intracranial grafting.
    Törnqvist N; Björklund L; Strömberg I
    Exp Neurol; 2001 Jun; 169(2):329-39. PubMed ID: 11358446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different developmental potentials of diencephalic and mesencephalic dopaminergic neurons in vitro.
    Engele J; Pilgrim C; Kirsch M; Reisert I
    Brain Res; 1989 Mar; 483(1):98-109. PubMed ID: 2565148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial stress-induced dopamine efflux and neuronal damage by malonate involves the dopamine transporter.
    Moy LY; Wang SP; Sonsalla PK
    J Pharmacol Exp Ther; 2007 Feb; 320(2):747-56. PubMed ID: 17090704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
    Nakao N; Nakai K; Itakura T
    Brain Res; 1997 Nov; 777(1-2):202-9. PubMed ID: 9449429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of GABA and GABA receptor inhibition on differentiation of mesencephalic precursors into dopaminergic neurons in vitro.
    Parga JA; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
    Dev Neurobiol; 2007 Oct; 67(12):1549-59. PubMed ID: 17525990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine synthesis precedes dopamine uptake in embryonic rat mesencephalic neurons.
    Fiszman ML; Zuddas A; Masana MI; Barker JL; di Porzio U
    J Neurochem; 1991 Feb; 56(2):392-9. PubMed ID: 1671084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of malonate toxicity in primary mesencephalic cultures using the GABA transport blocker, NO-711.
    Stokes AH; Bernard LP; Nicklas WJ; Zeevalk GD
    J Neurosci Res; 2001 Apr; 64(1):43-52. PubMed ID: 11276050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism.
    Zeevalk GD; Manzino L; Hoppe J; Sonsalla P
    Eur J Pharmacol; 1997 Feb; 320(2-3):111-9. PubMed ID: 9059843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tirilazad mesylate improves survival of rat and human embryonic mesencephalic neurons in vitro.
    Othberg A; Keep M; Brundin P; Lindvall O
    Exp Neurol; 1997 Oct; 147(2):498-502. PubMed ID: 9344573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Co-grafts of muscle cells and mesencephalic tissue into hemiparkinsonian rats: behavioral and histochemical effects.
    Kaddis FG; Clarkson ED; Bell KP; Choi PK; Freed CR
    Brain Res Bull; 2000 Feb; 51(3):203-11. PubMed ID: 10718512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture.
    Antonelli T; Tomasini MC; Finetti S; Giardino L; Calzà L; Fuxe K; Soubriè P; Tanganelli S; Ferraro L
    J Neurosci Res; 2002 Dec; 70(6):766-73. PubMed ID: 12444598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocyte-regulated GABA-ergic striatal neurons development: an in vitro ultrastructural study.
    Autillo-Touati A; Rouget M; Araud D; Prochiantz A; Seite R
    J Hirnforsch; 1993; 34(3):291-7. PubMed ID: 8270783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotoxic effects of papaverine, tetrahydropapaverine and dimethoxyphenylethylamine on dopaminergic neurons in ventral mesencephalic-striatal co-culture.
    Goto K; Mochizuki H; Hattori T; Nakamura N; Mizuno Y
    Brain Res; 1997 Apr; 754(1-2):260-8. PubMed ID: 9134983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxic and protective effects of L-dopa on mesencephalic cell cultures.
    Mytilineou C; Han SK; Cohen G
    J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment.
    Zhou J; Bradford HF; Stern GM
    Brain Res; 1994 Sep; 656(1):147-56. PubMed ID: 7804829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
    Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
    Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.